Abstract 7702: Integrin αvβ3-driven secretome remodeling uncovers THBS1 as a potential prognostic mediator in cutaneous T-cell lymphoma
Mercedes Debernardi(Instituto de Investigaciones Biomédicas en Retrovirus y Sida), Florencia Cayrol(Consejo Nacional de Investigaciones Científicas y Técnicas), Ingrid L.M. Souza(Fundação Carlos Chagas), Alejandro Correa Dominguez(Fundação Carlos Chagas), Karina Formoso(Pontificia Universidad Católica Argentina), Graciela Cremaschi(Pontificia Universidad Católica Argentina), Lucero Alvarado(Pontificia Universidad Católica Argentina), Alejandro J. Cagnoni(Experimental Medicine and Biology Institute)
Cited by 0
Related Papers
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors
|Nature Communications|2017|108
Inhibition of Integrin αVβ3 Signaling Improves the Antineoplastic Effect of Bexarotene in Cutaneous T-Cell Lymphoma
|Molecular Cancer Therapeutics|2022|6
TRPC absence induces pro-inflammatory macrophages and gut microbe disorder, sensitizing mice to colitis
|International Immunopharmacology|2022|5
SUN-LB054 Cilengitide Reverts Thyroid Hormones Effects in Bexarotene Treatment of Breast Cancer Cells
|Journal of the Endocrine Society|2019|1
PKCα Activation via the Thyroid Hormone Membrane Receptor Is Key to Thyroid Cancer Growth
|International Journal of Molecular Sciences|2024|1